| Vol. 12.05 – 9 February, 2021 |
| |
|
|
| Researchers performed a transcriptomic analysis of the microenvironment of 4,655 diffuse large B-cell lymphomas from multiple independent cohorts and described four major lymphoma microenvironment categories that associate with distinct biological aberrations and clinical behavior. [Cancer Discovery] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists identified rare LNGFR+ cells in human fetal and regenerative bone marrow that co-expressed endothelial and stromal markers. This endothelial subpopulation displayed transcriptional reprogramming consistent with endothelial-to-mesenchymal transition and could generate multipotent stromal cells that reconstituted the bone marrow niche upon transplantation. [Cell Stem Cell] |
|
|
|
| Investigators used a humanized globin-cluster sickle cell disease mouse model to study Cas9-AAV6-mediated beta-globin-correction in functional hematopoietic stem cells within the context of autologous transplantation. [Nature Communications] |
|
|
|
| The authors showed that Mediator interacted directly with E2A-PBX1 through an interaction of the MED1 subunit with an E2A activation domain. Results of MED1 depletion by CRISPR/Cas9 further indicated that MED1 was specifically required for E2A-PBX1–dependent gene activation and leukemic cell growth. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers exploited gene targeted and transgenic mice, and demonstrated that signal-transducing adaptor protein-2 was not required under normal, steady-state conditions. [Haematologica] |
|
|
|
| Scientists revealed for the first time that cellular O‐GlcNAcylation levels declined along the course of megakaryocyte differentiation from human‐derived hematopoietic stem and progenitor cells. [Stem Cells] |
|
|
|
| Investigators demonstrated that nicotinamide phosphoribosyltransferase (NAMPT) was indispensable for the maintenance, survival, and hematopoietic differentiation of induced pluripotent stem cells. [Stem Cell Research & Therapy] |
|
|
|
| Scientists investigated the anti-leukemic effect of the new Calothrixin B derivative, L20, and studied the underlying mechanisms. Cytotoxicity analysis of L20 revealed that it showed significant IC50 concentrations in HEL cells at low doses than in K562, and KG-1a. [Biomedicine & Pharmacotherapy] |
|
|
|
| Chronic stimulation with Toll-like receptor (TLR)4 or TLR2 ligands resulted in an expansion of phenotypic HSCs with reduced self-renewal capacity and enhanced myeloid differentiation. [Experimental Hematology] |
|
|
|
|
| The authors explore the role of the multicellular hematopoietic stem cell niche in hematopoiesis and inflammation, and the potential contribution of this niche to the hematopoietic response to obesity. [JCI Insight] |
|
|
|
|
| Bristol Myers Squibb announced that the European Commission has granted full Marketing Authorization for Inrebic® for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis, who are Janus Associated Kinase inhibitor naïve or have been treated with ruxolitinib. [Bristol Myers Squibb] |
|
|
|
|
| May 17 – 21, 2021 Virtual |
|
|
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| University of Oxford – Oxford, England, United Kingdom |
|
|
|
| Blood Research Institute – Milwaukee, Wisconsin, United States |
|
|
|
| The University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| St. Jude Children’s Hospital – Memphis, Tennessee, United States |
|
|
|
|